Welcome to the 2019 edition of the annual joint conference of the King Hussein Cancer Center, The American University of Beirut Medical Center, and MD Anderson Cancer Center.
Each year, researchers from the three institutions present the latest collaborative work in oncology research and standards of care, in addition to discussing prospective projects to be jointly pursued. In collaboration with MD Anderson Cancer Center, the King Hussein Cancer Center and the American University of Beirut Medical Center continue to lead the way in innovative medical research and education across the MENA region.

Conference Schedule

Hematologic Malignancies

Time Topic Speaker
8:25 Welcome Remarks Dr. Asem Mansour
Session-I Moderators: Dr. Nazmi Kamal, Dr. Amal Abu Ghosh, Dr. Jean El-Cheikh
8:30-8:55 Acute lymphocytic leukemia Dr. HagopKantarjian
8:55-9:20 Acute Myeloid Leukemia Dr. FarhadRavandi
9:20-9:45 Acute Myeloid Leukemia in Elderly Dr. Amer Zeidan
9:45-10:00 Q&A
10:00-10:25 Coffee Break & Poster View
Session-2 Moderators: Dr. Ahmad Telfah, Dr. Husam Abu Jazar, Dr. Khalid Halahleh
10:25-10:50 Allogeneic Stem Cell Transplantation Dr.Ali Bazarbachi
10:50-11:15 Chronic Myeloid Leukemia Dr. HagopKantarjian
11:15-11:40 Myelodysplastic syndromes Dr. Amer Zeidan
11:40-11:50 Q&A
11: 50- 1:10 LUNCH and Jumah Prayers
Session-3 Moderators: Dr. Ali Bazerbashi,  Dr. Sana Al-Sukhun, Dr. Abdelghani Tbakhi
1:10-1:35 The Highly Curable Leukemia’s Dr. FarhadRavandi
1:35-2:00 Multiple Myeloma Dr. Sameer Yaser
2:00-2:25 Acute lymphocytic leukemia Dr. HagopKantarjian
2:25-2:50 Update on CAR-T Therapy Dr. Jean El-Cheikh
2:50- 3:00 Q&A
3:00-3:30 Coffee Break & Poster View
Session-4 Moderators: Dr. Abdallah Al-Abbadi, Dr. Lina Marie, Dr. Salwa Saadeh
3:30-3:40 O-1; Comparable efficacy of peripheral stem  cell mobilization using biosimilar G-CSF Nivestim(R) to original Neupogen(R)  in healthy donors Dr. Rula Najjar
3:42-3:52 O-2; safety and efficacy of 4 cycles of  BrentuximabVedotinas  consolidation after autologous  peripheral stem cell  transplantation in  relapsed/refractory Hodgkin’s lymphoma Dr. JeriesKort
3:54-4:04 O-3; The role of Anti-thymocyte globulin with Thiotepa-Busulfan-fludarabine based conditioning in patients undergoing  haploidentical stem cell transplant and post-transplant cyclophosphamide. Dr. Jean El-Cheikh
4:06-4:16 O-4; Imatinibmesylate is safe and effective in maintaining cytogenetic and molecular response achieved with 1 year nilotinib first line in newly diagnosed chronic myeloid leukemia: preliminary results of a prospective clinical trial Dr. Nour M. Moukalled
4:18-4:28 O-5; Hematopoietic recovery and transfusion  needs after Haploidentical stem cell transplantation with post-transplant  cyclophosphamide in adult patients with  hematologic malignancies Dr. Razan Mohty
4:30-4:40 O-6; The value of interim FDG- PET/CT in  assessing response to therapy in Hodgkin Lymphoma patients at King Hussein Cancer Center (KHCC) Dr. Farah Anwer
4:42-4:52 O-7; Outcome of Relapsed Acute Lymphoblastic Leukemia in Children and Adolescent Treated At King Hussein Cancer Center Dr. Mayada Abu Shanap
4:55-5:00 Closing Remarks; Dr. HagopKantarjian
5:00-5:30 Reception
5:30- 6:30 Opening Ceremony

Research Day

Time Hall-A/ Fourth Floor
08:15-10:30 Session-1/ Plenary Session
Moderators: Dr. Ali Taher, Dr. Mahmoud Al-Masri, Dr. Fady  Geara; Dr. Ali Al Ebous
08:15-08:30 Welcome Remarks
08:30-08:40 O-8; Activation of androgen receptor induces  epithelial-to-mesenchymal transition of  molecular apocrine breast MDA-MB-453 cancer cells: alterations of a molecular  network Dr. Mamoun Ahram
08:42-08:52 O-9;  Investigating the diagnostic accuracy of  CT, 18F-FDG PET/CT and EBUS/TBNA in  preoperative mediastinal nodal staging  of NSCLC Dr.Akram Al-Ibraheem
08:54-09:04 O-10;  Deep Targeted Sequencing Analysis of  Hot Spot Mutations in Non-small Cell  Lung Cancer Patients from the Levant Dr. Ghina Fakhri
09:06-09:16 O-11;  Postmastectomy Radiation Therapy: “No One Size Fits All” Dr. Youssef H. Zeidan
09:18-09:28 O-12; Intravenous Ferric Carboxymaltose (FCM), without Erythropoiesis-Stimulating Agents  (ESA), is Safe and Effective  in the Treatment of Chemotherapy Induced  Anemia (CIA) Dr. Hikmat Abdel-Razeq
09:30-09:40 O-13;  Salvage chemotherapy using irinotecan  and temozolamide in pediatric and  adult populations with relapsed Ewing Sarcoma Dr. Samer Salah
09:42-09:52 O-14; CYR61/CCN1 Expression in Resected Pancreatic Adenocarcinoma Dr. Christelle Dagher
09:54-10:04 O-15;  Modeling EGFR mutation detection for liquid biopsy Dr. Osama Alsmadi
10:06-10:16 O-16; Diagnostic Performance of FDG-PET/ CT scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Patients with Newly Diagnosed Breast Cancer Dr. Vanessa Akiki
10:30-11:00 Coffee Break and Poster View
Hall-A/ Fourth Floor Hall-B/ Sixth Floor
11:00-13:00 Session-2/ Breast Moderators: Dr. Hazem Assi,  Dr. Said Al-Natour, Dr. Ghadeer Abdeen Session-3/ Lung Moderators:  Dr. Akram Al-Ibraheem, Dr. Feras Hawari, Dr. Abdulmajeed Dayyat
11:00-11:28 Year-in-Review; Dr. Nagi Al Saghair Year-in-Review; Dr. Arafat Tfayli
11:30-11:40 O-17; Androgen receptor influences behavior of breast cancer cells via microRNAs: evidence of stronger transcriptional than post-transcriptional regulation Dr. Mamoun Ahram O-24; Effect of PD-L1 Expression on Survival in Advanced Stage NSCLC Patients Harboring EGFR mutations and Receiving EGFR TKIs Dr. Kamal Alrabi
11:42-11:52 O-18; Genetic Counseling and Genetic Testing for Germline BRCA1/2 Mutations among High Risk Breast Cancer Patients in Jordan, a Study of 500 Patients Dr. Hikmat Abdel-Razeq O-25; Prevalence of Programmed Death Ligand 1 in Patients Diagnosed with Non-Small Cell Lung Cancer in the Levant Majd Al-Assad
11:54-12:04 O-19; Availability, Rate of Usage, and Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early-Stage Breast Cancer Patients in Lebanon Dr. Nour Abdul Halim O-26; Neutrophil Lymphocyte Ratio Association with Baseline Brain Metastasis in Stage IV Non-Small Cell Lung Cancer Dr. Kamal Alrabi
12:06-12:16 O-20; Breast Cancer among Elderly Jordanian Patients; Tumor Characteristics, Treatment Modalities and Outcomes Dr. Hikmat Abdel-Razeq Session-4/ Genitourinary Moderators: Dr. Ali Al Daghmin, Dr. Imad Jaradat, Dr. Mohammad Salameh  
12:18:12:28 O-21; Effectiveness of Cyanoacrylate (Glubran 2(R)) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection, Randomized controlled trial Dr.  Mahmoud Al-Masri O-27; Establishment and Characterization of Prostate Cancer Patient-derived Organoids and Cells Dr. Wassim Abou-Kheir
12:30-12:40 O-22; Amenorrhea and Fertility Preservation among Young Women Treated with Chemotherapy for Early-Stage Breast Cancer Dr. Omar Shahin O-28; Prostate cancer (PC) in the Jordanian population: Disease trends and outcomes at King Hussein Cancer Center (KHCC) Dr. Amal Al-Omari
12:42-12:52 O-23; Fertility in Breast Cancer Survivors Following Breast Cancer Treatment at AUBMC: A Retrospective Study Dr. Rasha Kakati O-29; EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence? Dr. Wassim Abou-Kheir
13:00-14:00 Lunch and Poster View
14:00-15:30 Session-5/Supportive care Moderators: Dr. Sami Al-Khatib, Dr. Hussein Abu Khudair, Dr. Debrah Mukhraji Session-6/ Pediatrics Moderators: Dr. Faris Madanat, Dr. Rawad Rihani, Dr. Hasan Hashem
14:00-14:10 O-30; Statin use improves the survival of colorectal cancer (CRC) patients in Jordan: An observational study at King Hussein Cancer Center (KHCC) Dr. Mahmoud A. Alfaqih O-37; Differential Gene Expression of Neuroblastoma Identifies a Pattern that Predicts Prognosis and Highlights the Role of Transcription Factor Activating Protein 2 beta (TFAP2B) in Spontaneous Regression of Stage 4s Dr. Iyad Sultan
14:12-14:22 O-31; Predictors of Augmented Renal Clearance in Critically-Ill Patients with Cancer Dr. Lama Nazer O-38; The Impact Of Retinoblastoma Screening Program for High Risk Children Dr. Yacoub A. Yousef
14:24-14:34 O-32; Impact of Using Perioperative Pulmonary Care Bundle on Postoperative Pulmonary Complications, Cancer Center Experience Dr. Riad Abdel Jalil O-39; Rb Awareness among First Contact Physicians in Jordan Dr. Tamara Alnawaiseh  
14:36-14:46 O-33; Fertility Counseling and Sperm Banking among Male Adolescents and Young Adults Treated for Cancer with Curative Intent in a Developing Country Dr. Hikmat Abdel-Razeq Session-7/ Sarcoma Moderators: Dr. Abdulla Nofal, Dr. Faiha Bazzeh, Dr. Samer Abdel Al
14:48-14:58 O-34; High Incidence of Venous Thromboembolic Events (VTE) in Patients with Diffuse Large B-Cell Lymphoma (DLBL) Dr. Mohammad Ma’koseh O-40; Timing of local control as a significant predictor of survival of patients with Ewing sarcoma of the extremities Dr. Samer Salah
15:00-15:10 O-35; Decision Making Preferences Among Patients with Advanced Cancer In A Tertiary Cancer Center in Jordan Dr. Mahmoud Abu Nasser O-41; Quality Assurance Rounds for Sarcoma Radiotherapy Patients: Twelve-Year Results Dr. Ramiz Abu-Hijlih
15:12-15:22 O-36; Original filgrastim (Neupogen(R) and biosimilar filgrastim (Nivestim(R)): Comparison of effectiveness and safety in primary prophylaxis of chemotherapy-induced febrile neutropenia Dr. Suzan Hammoudeh O-42; The Outcome of Limb Salvage Surgery in Developing Country, KHCC Experience Dr. Ahmad Shehadeh
15:30-16:00 Coffee Break and Poster View
16:00- Hall-A/ Fourth Floor Session-8/General
Moderators: Dr. Faiez Daoud, Dr. Omar Shamieh, Dr. Abdulla Al-Rashdan
16:00-16:10 O-43; Body Mass Index (BMI) and Long Term Outcomes in Patients with Colorectal Cancer (CRC) at King Hussein Cancer Center (KHCC) Dr. Amal Al-Omari
16:12-16:22 O-44; Laparoscopic versus open pancreaticoduodenectomy: a case-matched comparative study Dr. Balqees Al-Omari
16:24-16:34 O-45; Knowledge, Attitudes and Practices (KAP) of Cancer Patients towards Biobanking in Jordan: A study at King Hussein Cancer Center (KHCC) Dr. Maysa Al-Hussaini
16:36-16:46 O-46; Female oncologists in the Middle East and North Africa: progress towards gender equality Dr. Yolla Haibe
16:48-16:58 O-47; Cytoreduction and Hyperthermic intraperitoneal chemotherapy in Lebanese patients in a single institution. A retrospective study Dr. Muhieddine Seoud
17:00-17:10 O-48; Early Stage Oral Tongue Squamous Cell Carcinoma: Treatment Outcomes and Analysis of Recurrence Risk Factors Dr. Issa Mohamad
17:12-17:20 O-49;  O-22; Laparoscopic versus open insertion of feeding gastrostomy tube in patients with head and neck cancers: a matched comparative study Dr. Basil Ammori
17:22-17:32 O-50; Clinical Characteristics and Treatment Outcome for Adult Medulloblastoma: A Tertiary Cancer Center Experience Dr. Abdelatif Almousa
17:34-17:44 O-51; Neuro-Onco-2; Prognostic Significance of O6-Methylguanine-DNA-methyltransferase (MGMT) Promoter Methylation and Isocitrate Dehydrogenase-1 (IDH-1) Mutation in Glioblastoma Multiforme Patients: A Single-Center Experience in the Middle East and North Africa (MENA) Region. Dr. Firas Kreidieh
17:45-18:00 Closing Remarks

Registartion

KHCC, AUBMC or MD Anderson Cacner Center Memebers

FREE
  • Plenary Sessions
  • Workshops
  • Conference Package
  • Coffee Breaks and Lunch
  • Certificate of Attendance
Register Now

Regular

$100
  • Plenary Sessions
  • Workshops
  • Conference Package
  • Coffee Breaks and Lunch
  • Certificate of Attendance
Register Now

Venue

W Hotel, Amman, Jordan

Visit Hotel’s Website for more details.

To book a room and use KHCC’s promo code, please follow this link: Reserve Now

Amman, Jordan

Rafiq Al Hariri Ave 13, Amman 11953

20+ Speakers

Speakers from all over the world

Official Sponsors & Partners

Who make this conference possible!

Diamond Sponsors

Platinum Sponsors

astrazeneca

Golden Sponsors

Janssen Logo

Silver Sponsors

phizer

The King Hussein Cancer Foundation

The King Hussein Cancer Foundation- Governing Body (The Foundation) is an independent, non-governmental, not-for-profit institution founded in 2001 by Royal Decree to combat cancer in Jordan and the Middle East region.